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Abstract Thyroid hormones exert profound effects on the
energy metabolism. An inspection of the early and more recent
literature shows that several targets at the cellular level have
been identified. Since their effects on the nuclear signalling
pathway have already been well-defined and extensively
reviewed, this article focuses on the regulation of mitochondrial
activity by thyroid hormones. Mitochondria, by virtue of their
biochemical functions, are a natural candidate as a direct target
for the calorigenic effects of thyroid hormones. To judge from
results coming from various laboratories, it is quite conceivable
that mitochondrial activities are regulated both directly and
indirectly. Not only triiodo-L-thyronine, but also diiodothyro-
nines are active in regulating the energy metabolism. They
influence the resting metabolism in rats with 3,5-diiodo-L-
thyronine seeming to show a clearer effect.
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1. Introduction
The thyroid gland primarily produces two hormones, L-thy-
roxine (T4) and triiodo-L-thyronine (T3). These hormones are
well known to exert profound e¡ects on the energy metabo-
lism. However, although the ¢rst evidence of an increase in
metabolic rate in subjects given thyroid extract was reported
at the end of the last century [1], the mechanism by which
thyroid hormones in£uence the energy metabolism is still
poorly understood. The roots of the currently favored hypoth-
eses and of the debate concerning the cellular mechanism of
action of thyroid hormones can be traced to early observa-
tions of their calorigenic e¡ects. The key experiments were
those performed by J.R. Tata and co-workers in the 1960s
[2,3]. These authors showed that administration of thyroid
hormones to hypothyroid rats induced an increase in their
basal metabolic rate, while simultaneous injection of an inhib-
itor of protein synthesis, such as the actinomycin D, com-
pletely inhibited the stimulatory e¡ect of T3. These results
implicated the nucleus as the prime candidate for the location
of the signalling pathway at the cellular level that is involved
in mediating the e¡ect of T3 on the energy metabolism. Mi-
tochondria, on the other hand, by virtue of their biochemical
functions, are natural candidates as the target for the calori-
genic e¡ects of thyroid hormones. This is also reasonable in
view of the extensive changes that occur in the mitochondrial
compartment in response either to thyroid hormones or the
physiological states that involve changes in the activity of the
thyroid gland (such as aging [4], exposure to cold [5,6], feeding
[7] and thyroid status [8]).
During the last three decades, on the basis of results pur-
porting to show either the mitochondrion or nucleus as the
location of the major signalling pathway, several mechanisms
have been proposed to explain the calorigenic e¡ects of thy-
roid hormones. However, none has received universal accept-
ance, possibly because of the perceived problems arising from
the wide variety of experimental methods and conditions used
in the various investigations (see [9]). Actually, the peripheral
availability of iodothyronines mostly depends on local deiodi-
nation of T4 and consequently on the activity of deiodinase
enzymes. For that reason, T4 deiodination is crucial in the
local homeostasis of thyroid hormones. The fact that deiodi-
nase enzymes respond in di¡erent ways to di¡erent treatments
(thyroidectomy, drug administration, etc., see [9]) could help
to explain some of the con£icting evidence about the e¡ects of
thyroid hormones. Moreover, the use of some of these treat-
ments could have led to the masking of some e¡ects actually
attributable to iodothyronines other than T4 and T3. Besides
T4, it is known that T3, rT3 and other iodothyronines are
substrates for deiodinase enzymes. If these enzymes are not
inhibited (or are activated), it is quite conceivable that some
e¡ects seen following T4 or T3 administration might actually
be due, at least in part, to some of their deiodinated products.
Studies of the e¡ects of iodothyronines at the mitochondrial
level have been mostly focused on T3, but recently diiodothyr-
onines (T2s), in particular 3,5-diiodo-L-thyronine (3,5-T2),
have been identi¢ed as possible peripheral mediators of the
e¡ect of thyroid hormones on cell respiration. This article will
give an overview of the actions that thyroid hormones exert
(both directly and indirectly) at the mitochondrial level. In
particular, it will focus on the e¡ects of diiodothyronines on
the mitochondrial energy transduction apparatus.
2. Thyroid hormones and mitochondria
Numerous reports concerning the e¡ects of T3 on mito-
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chondrial activity can be found in the literature (for review see
[10]). Some of these reported e¡ects are summarized in Table 1
and, in one way or another, they are all related to the e¡ects
that thyroid hormones exert on the cellular respiration (calo-
rigenic e¡ect). The oldest hypothesis put forward to explain
the calorigenic e¡ect of T3 was that of Martius and Hess [11].
These authors obtained the ¢rst evidence that the in vitro
addition of T4 to mitochondria caused uncoupling, as meas-
ured by a decrease in the respiratory control ratio (RCR = res-
piratory state in which ATP synthesis is at the maximal rate
(state 3)/respiratory state in which there is no ATP synthesis
(state 4)) [11]. This hypothesis was subsequently discarded and
regarded as not physiologically relevant since (i) large concen-
trations of T3 or T4 were required and (ii) the e¡ects seen
with thyroid hormone in vitro were not observed in vivo.
Actually, mitochondria from animals in di¡erent thyroid
states do not show any di¡erences in RCR. This absence of
a change in RCR, however, does not exclude the possibility
that changes in state 3 and/or state 4 may occur. In fact, a
concomitant increases in (i) the proton leak kinetic (enhanced
proton conductance of the inner membrane), which is mostly
responsible for state 4 of respiration, and (ii) phosphorylating
machinery kinetic (ATP synthase, adenine nucleotide trans-
locator, phosphate transporter), which is responsible for
state 3 of respiration, can lead to an unchanged set-point for
the coupling ratio [12]. Indeed, when compared to those from
euthyroid animals, mitochondria isolated from hypothyroid
animals display lower values of state 4 and state 3 respiratory
rates, while mitochondria from hyperthyroid rats show higher
values. The mitochondrial proton motive force, on the other
hand, decreased in the order hypothyroids euthyroids hy-
perthyroid [13]. An uncoupling e¡ect of T3 seems therefore
to be a real e¡ect and not an artifact. The molecular mecha-
nism underlying these e¡ects, however, is not completely de-
¢ned. Harper and co-workers [14] related the increase in the
mitochondrial proton leak elicited by T3 to an elevated per-
meability of the phospholipid bilayer due to a change in the
lipid composition of the inner mitochondrial membrane. Re-
cently, however, the discovery that uncoupling proteins
(UCPs) are not present exclusively in brown adipose tissue
(BAT), but in almost all tissues, shed new light on the mech-
anism of mitochondrial uncoupling and on the role played by
thyroid hormones.
UCPs produce heat by generating a pathway that allows
dissipation of the proton electrochemical gradient across the
inner mitochondrial membrane without a coupling to any
other energy-consuming process. Besides the UCP present in
BAT (termed UCP1), other UCPs (termed UCP2, UCP3 and
UCP4) are expressed in several tissues in humans and rats (for
review see [15], see also [16]). It has recently been shown that
T3 stimulates the expression of the mRNAs for both UCP2
[17,18] and UCP3 [19] and that a good correlation exists be-
tween UCP3 mRNA expression, mitochondrial coupling and
the thyroid state [20]. This is particularly intriguing in view of
(i) the evidence that a signi¢cant proportion of an organism’s
resting oxygen consumption is dedicated to opposing the pro-
ton leak and (ii) the old hypothesis of ‘thyroid-induced un-
coupling’. Uncoupling e¡ects may also be elicited through the
ADP/ATP carrier (AAC) involved in the mechanism of the
uncoupling e¡ect produced by long chain fatty acids [21].
Thyroid hormones, in fact, also regulate the expression of
the mRNA for AAC [22].
These e¡ects on the expression of genes involved in the
function of the mitochondrial energy transduction apparatus
belong to the nuclear-mediated e¡ects of thyroid hormones.
However, they are relevant to the present review because one
of the questions that intrigues most of the investigators study-
ing ‘thyroid hormones and energy metabolism’ is : ‘are the
mitochondria a direct or an indirect target of the e¡ect exerted
by T3 on the energy metabolism at the cellular level?’. This
question has generated several possible answers. The most
widely accepted idea is that held by those scientists who be-
lieve that the e¡ects exerted by T3 on mitochondrial activities
are indirect, all of them being mediated by an early e¡ect at
the nuclear level. These investigators are convinced of this for
two main reasons. The ¢rst is that some results apparently
showing a direct e¡ect of thyroid hormones at the mitochon-
drial level seem not to be reproducible or they are ambiguous
or they were obtained at very high doses. The second is that
the nuclear pathway, by contrast, is well-established and much
progress has been made in the last three decades in our under-
standing of this pathway.
2.1. Mitochondria as an indirect target
In the last few years, it has been demonstrated that T3
exerts profound e¡ects on the expression of several genes.
These e¡ects of T3 at the genomic level are mediated by the
nuclear T3 receptor (TR). This TR is intimately associated
with chromatin and binds thyroid hormone with a high-a⁄n-
ity and speci¢city. The c-erbA proto-oncogene, the counter-
part of the viral v-erbA oncogene, encodes the high-a⁄nity
TR. There are two genes, designated c-erbAK (TRK) and c-
erbAL (TRL), encoding several thyroid receptor isoforms. (1)
The TRK gene, by alternative splicing, gives rise to TRK1 and
TRK2 and, by expression of an alternative strand, to Rev-
ErbAK. TRK2 is also known as c-ErbAK2 or TRvariantK2,
it does not bind T3 and, therefore, cannot be considered a
true receptor. (2) The TRL gene, through the use of alterna-
Table 1
Reported e¡ects on mitochondrial parameters exerted by thyroid hormones (T4 of T3)
Parameters Reported changes
H/O ratio 3 or u
P/O ratio 3 or s
Proton leak u
Proton slip u
Proton motive force (vpH and membrane potential) 3 or u or s
Activity of mitochondrial carriers (ADP/ATP carrier, UCPs) u
Activity of electron transport chain components u
Activity of mitochondrial enzymes (K-glycerophosphate dehydrogenase, succinic dehydrogenase, NADH dehydrogenase) u
Changes induced: 3 no change, u increase, s decrease. Note that con£icting results have been reported for some parameters.
For publication details of the papers reporting the e¡ects shown in this table, see Table 1 on page 11 of [10].
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tive promoters, gives rise to TRL1 and TRL2. Both are able to
bind T3.
T3 receptors are transcription factors. They modulate tran-
scription mainly by binding to speci¢c DNA sites known as
‘thyroid hormone response elements’ (TREs). In the absence
of T3, the TR has an intrinsic transcriptional repressor func-
tion. In most cases, the TRs act as heterodimers with the 9-cis
retinoic acid receptor (RXR), but there are also multiple TR
complexes that bind to TREs. In addition to RXR, in fact,
many other molecules are directly or indirectly functionally
associated to TRs (vitamin D3, peroxisome proliferator-acti-
vated receptor (PPAR), co-repressors, co-activators, etc.).
However, these aspects of the molecular mechanisms involved
in the nuclear pathway that mediates the action of thyroid
hormone have been recently discussed in a number of excel-
lent reviews [23^25], so they will not be discussed further in
this article.
Activation or inhibition of nuclear gene transcription by
T3, however, may be relevant to some e¡ects that T3 exerts
at the mitochondrial level. The regulation of the mitochon-
drial respiratory function by T3 may also be consequent upon
a change in the expression of genes encoding components of
the mitochondrial respiratory apparatus (respiratory genes) or
components that activate or inhibit the mitochondrial ge-
nomic apparatus (for review see [26]). In mammals, about
100 gene products are necessary for the biogenesis of the
mitochondrial respiratory apparatus and they are principally
encoded in the nucleus. At present, it appears that only 13
mitochondrial components are encoded in the mitochondrial
genome.
2.2. Nuclear-encoded respiratory genes
While it is known that T3 in£uences (in the rat) the expres-
sion of nine nuclear-encoded respiratory genes [26], it is not
clear at the moment whether or not these e¡ects on the res-
piratory genes are mediated by a direct interaction of T3-TR
complexes with TREs. Among these nine genes, only the pro-
moter region of the liver cytochrome c has been characterized
and, in transient transfection experiments, it did not support a
T3-TRs-mediated induction of expression [27]. Work on hu-
man cytochrome c1 and ATP synthase subunit genes further
supports the idea that di¡erent mechanisms may underlie the
e¡ects of T3. Both contain putative TREs, but while the cy-
tochrome c1 promotor supports a TR-mediated induction of
expression, the TRE of the F1-ATP synthase subunit does not
(for review see [26], see also [28,29]). In addition, a direct
interaction of T3-liganded TRs with TREs should elicit a
rapid induction, as seen for ‘spot 14’ (20 min), rat liver glu-
cokinase and rat growth hormone (2 h) and rat phosphoenol-
pyruvate-carboxykinase (3 h). However, in the heart, direct
T3-TRE induction of the K-myosin heavy chain gene and of
calcium-ATPase takes 24^36 h to reach a maximal e¡ect after
T3 injection. As for the nuclear-encoded respiratory genes, the
induction of mRNA levels by T3 usually reaches its maximum
at 12^36 h, with the exception of glycero-3-phosphate dehy-
drogenase and the LF1-ATPase subunit (for an account of all
these aspects of the subject, see [26]). In summary, there is no
conclusive evidence that a direct T3-TR interaction is always
involved in the regulation of the transcription of respiratory
genes. This raises the question as to how T3 might regulate
respiratory gene expression if not via the thyroid receptor. A
possible mechanism could be the stimulation of transacting
factors which, in turn, activate the expression of the respira-
tory genes. These factors could include nuclear respiratory
factor (NRF-1), which binds to the consensus sequences
present in several nuclear-encoded respiratory genes [27]. In-
deed, NRF-1 responds to T3 and represents a potential link
between T3 stimulation and selective regulation of the expres-
sion of respiratory genes including mitochondrially encoded
genes.
2.3. Mitochondrially encoded genes
In mitochondria, the genome is transcribed into 16 kb poly-
cistronic RNA molecules, the transcription being initiated at a
dual promoter sequence located in the D-loop region of the
mitochondrial DNA (mtDNA) (for review see [30]). In early
work, it was demonstrated (using non-speci¢c substrates) that
thyroid hormone regulates the rate of RNA synthesis [31].
More recently, it was shown that the steady-state concentra-
tion of all mitochondrial RNAs was increased 2^8-fold after
1^3 days of T3 treatment. Analysis of transcripts showed that
part or all of the increase was accounted for by an elevated
synthesis [32]. These results, which have been con¢rmed by
other groups, support the idea that the mitochondrial protein
synthesis is regulated by T3 at the transcriptional level. Two
alternative mechanisms have been proposed to explain the
regulation of mtDNA transcription by T3, through the acti-
vation of the expression of a mitochondrial transcription fac-
tor (mitochondrial transcription factor A (mtTFA)) [33,34] or
directly through speci¢c mitochondrial T3 receptors [35,36].
3. Non-nuclear action of iodothyronines: the direct
mitochondrial pathway
As discussed before, the latency of the response to T3 is not
an appropriate way to discriminate a nuclear-mediated e¡ect
of T3 from other, extranuclear, e¡ects. This being so and in
view of the presence of a mitochondrial genomic apparatus
(which prevents us distinguishing between ‘genomic’ and ‘non-
genomic’ e¡ects), it would be preferable to divide the e¡ects
due to the iodothyronines into ‘nuclear-mediated’ (or nuclear)
and ‘non-nuclear-mediated’ (or extranuclear) e¡ects. The nu-
clear-mediated e¡ects have been brie£y described above and
they have been extensively described by others [23^26]. The
non-nuclear e¡ects of thyroid hormones include all those ef-
fects or mechanisms for which a nuclear genomic dependence
can be excluded.
In recent years, an increasing number of non-nuclear e¡ects
of iodothyronines have been described. Non-nuclear e¡ects
have been reported to occur in several compartments of the
cell including most cell organelles, the plasma membrane, the
cytoskeleton and the cytoplasm (for review see [37]). The la-
tency to onset and other features di¡erentiate the nuclear
from the extranuclear actions of iodothyronines. Unlike the
nuclear actions, the extranuclear e¡ects are mostly evident
within a short time (minutes or a few hours), show a better
structure-activity relationship (they can be induced by iodo-
thyronine analogues that have modest or no activity at the
nuclear TR, such as T4, rT3, T2 etc.) and may be mediated by
signal transducing pathways (cAMP, protein kinase, inositol-
phosphate). As the e¡ects that iodothyronines may exert di-
rectly at the mitochondrial level are relevant to the present
article, we shall focus our attention on them. There are some
characteristics that need to be displayed by a given e¡ect
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before we can accept that it is mediated by a direct action on
mitochondria. (a) It should be protein synthesis-independent,
(b) it should be observable in vitro in a nuclei-free system and
(c) it should be rapid in onset. In addition to all this, speci¢c
binding sites for iodothyronines should be present in mito-
chondria.
3.1. Mitochondrial binding sites
High-a⁄nity binding sites for T3 were identi¢ed in the mi-
tochondrial inner membrane in 1975 by Sterling et al. [38]. We
con¢rmed the existence of such sites in 1981 [39]. However, in
spite of this and several reports of rapid e¡ects of T3 on
mitochondria, the very existence and the physiological signi¢-
cance of these sites and of these e¡ects have long been con-
troversial. Further, a speci¢c mitochondrial receptor for T3
has still not been identi¢ed. Quite recently, however, the ex-
istence of speci¢c mitochondrial binding sites for T3 has re-
ceived additional con¢rmation from the work of Morel et al.
[40] and Wrutniak et al. [36].
Morel et al. [40] studied the kinetics of the internalization
and speci¢c subcellular binding of T3 in mouse liver both in
vivo and in vitro. These authors showed by quantitative elec-
tron microscopy autoradiography that, after the injection of
radiolabelled T3, speci¢c binding was displayed by ¢ve cell
compartments (including mitochondria). Surprisingly, speci¢c
binding was not evident in the cytosol, in which T3-binding
proteins are found. Cabello’s group [36], using a photoa⁄nity
labelling technique, identi¢ed two T3-binding proteins in rat
liver mitochondrial extracts. One (molecular weight (MW) 43
kDa) was located in the matrix and the other (MW 28 kDa) in
the inner membrane. These results are in partial agreement
with the results obtained by Sterling et al. [38] and by us
[39]. The same group [36], using antibodies against the two
binding domains of c-erbA K1 identi¢ed, by Western blot, two
proteins (mitochondrial matrix T3-binding protein (p43) and
inner mitochondrial membrane T3-binding protein (p28))
whose location and molecular weight were identical to the
mitochondrial T3-binding proteins previously described. Bi-
gler et al. [41] had previously demonstrated that truncated
c-erbAK1 proteins are synthesized from the c-erbA mRNA
encoding the full-length TR (47 kDa) by using an internal
AUG codon. Using an expression vector provided by these
authors, Wrutniak et al. [36] overexpressed a truncated 43
kDa c-erbAK1 protein in CV1 cells and, by cyto-immuno-
£uorescence experiments, demonstrated that this truncated
TRK protein is speci¢cally imported into mitochondria. Inter-
estingly, the same authors have identi¢ed ¢ve sequences highly
related to TRE within the rat mitochondrial genome and they
showed that p43 binds to one of these sequences in the D-loop
region, which contains the promoters of the mitochondrial
genome. These results are very intriguing and suggest the
hypothesis that p43 could function as a T3-dependent mito-
chondrial transcription factor.
All these data suggest that mitochondria could be an im-
portant direct target for T3, even though a possible involve-
ment of p43 in the e¡ect exerted by T3 on the energy metab-
olism has not yet been thoroughly investigated. However, this
does not exclude the possibility that mitochondrial binding
sites for T3 may play a very important physiological role in
regulating the mitochondrial transcription apparatus. This is
reasonable for two reasons, (a) T3 in£uences the mitochon-
drial biogenesis and turnover, (b) the mitochondrial biogene-
sis or turnover needs the coordinated participation of the
nuclear and mitochondrial genetic apparatus. In fact, the early
results obtained by us and by others showing that T3 regu-
lates the mitochondrial population and the mitochondrial nu-
cleic acid level [31,32,42,43] already suggested just such a pos-
sibility. Results seeming to con¢rm this possibility were
obtained by Martino et al. [44], who showed a direct action
of T3 on mitochondrial RNA-polymerase in isolated mito-
chondria, and very recently by Enriquez et al. [45]. The latter
authors studied the e¡ect of T3 (both in vivo and in vitro) on
in organello mtDNA transcription and on the in organello
footprinting patterns in the mtDNA regions involved in the
regulation of transcription. They con¢rmed a direct in£uence
of T3 on the mitochondrial transcription apparatus and, in
particular, they showed that T3 selectively modulates the al-
ternative H-strand transcription initiation sites without a pre-
vious activation of nuclear genes.
3.2. Diiodothyronines and mitochondria
In the last decade, a growing number of researchers have
been focusing their attention on the possibility that iodothyr-
onines other than T4 and T3 may be active in regulation of
the energy metabolism. In particular, several studies have sug-
gested that diiodothyronines such as 3,5-T2 and 3,3P-diiodo-L-
thyronine (3,3P-T2) could be of biological relevance.
As mentioned above, in 1981, we con¢rmed the presence of
T3-binding sites in a rat liver extract rich in inner mitochon-
drial membranes but, quite surprisingly, these sites also
showed a great a⁄nity for 3,3P-T2 [39]. In view of the fact
that such a molecule was considered a biologically inactive
product of T4 or T3 catabolism, these observations generated
some doubts about the physiological relevance of these sites.
More recently, however, Horst et al. [46] demonstrated that
3,5-T2 stimulates oxygen consumption in isolated perfused rat
liver (other analogues had no e¡ect). In the same study, T3
also showed a stimulatory e¡ect but it was completely abol-
ished by the addition to the perfusion medium of propylth-
iouracil (PTU), suggesting that T3 stimulates oxygen con-
sumption only after its transformation to 3,5-T2 (even if the
biochemical pathway leading to the formation of 3,5-T2
through T3 deiodination has still not been demonstrated).
These results encouraged us and others to start making
greater e¡orts to uncover a putative physiological role for
iodothyronines other than T4 and T3 in regulation of the
energy metabolism. As part of this e¡ort, we have shown
that chronic administration (3 weeks) of either 3,5-T2 or
3,3P-T2 signi¢cantly enhances both the mitochondrial respira-
tory rate and cytochrome c-oxidase (COX) activity [47,48]. T3
also had a stimulatory e¡ect but showed a di¡erent initial
time course, the e¡ect of the T2s was signi¢cant 1 h after
the administration of a single dose, while the e¡ects of T3
were signi¢cant only after 24 h. In the same studies, it was
also observed that other iodothyronines (3P,5P-T2, 3-T1, T0)
had no e¡ect on the COX activity. These results induced us to
focus our attention on two of the diiodothyronines, 3,3P-T2
and 3,5-T2.
The metabolic e¡ects of 3,5-T2 have also been demon-
strated by others in rats [49] and humans [50]. O’Reilly and
Murphy [49] also showed that these e¡ects are independent of
protein synthesis. A rapid stimulation of rat liver cytochrome
oxidase activity by T2s has also been demonstrated in vitro in
a nuclei-free system [51].
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The direct e¡ects of 3,5-T2 on the mitochondrial metabo-
lism have been con¢rmed in mitochondria isolated from the
liver and red muscle of the gold¢sh [52], thus indicating that
the in£uence of T2s is not restricted to mammalian species.
All these date strongly suggest that a direct mitochondrial
pathway, without nuclear mediation, underlies the e¡ects ex-
erted by T2s on mitochondrial activities. If this is so, speci¢c
binding sites for T2s should be present in mitochondria. In
fact, saturable binding sites for both 3,5-T2 and 3,3P-T2 have
been detected in rat liver mitochondria [53,54]. These sites
exhibit a high-a⁄nity and low-capacity, characteristics that
support their possible role as mitochondrial speci¢c sites
that could mediate the e¡ects of T2s. The exact biochemical
nature of these sites, however, remained unidenti¢ed.
By top-down elasticity analysis, we have shown a stimula-
tion of the activity of both cytochrome c-oxidizers and the
cytochrome c-reducers components of the respiratory chain,
1 h after the injection of 3,5-T2 [55]. These data suggest that
3,5-T2 may interact with some components of the respiratory
chain and they are in agreement with previous results showing
a direct stimulation of COX activity in experiments using the
isolated enzyme from bovine heart [56]. In a recent report,
Arnold and Kadenbach [57] showed that (in addition to the
mitochondrial membrane potential, the substrate pressure in
the respiratory chain and the oxygen concentration) the res-
piration of animal cells is also controlled by the matrix ATP/
ADP ratio, via an interaction of nucleotides with COX. In
fact, ATP produces an allosteric inhibition of the COX activ-
ity. In a further investigation, Arnold et al. [58] showed that
3,5-T2 speci¢cally binds to subunit Va of the COX complex
and completely abolishes the allosteric inhibition of respira-
tion induced by ATP. More recently, Arnold and Kadenbach
(personal communication) found that 3,5-T2 induces a de-
crease in the RCR of COX, based on vp. Subunit Va of the
COX complex is a candidate to be the receptor mediating the
e¡ects that this iodothyronine exerts at the mitochondrial lev-
el. Overall, these e¡ects should result in an in£uence of 3,5-T2
on the metabolic rate and thermogenesis in vivo.
Evidence supporting these conclusions has in fact been ob-
tained in our laboratory. We have shown that T2s enhance
the resting metabolic rate (RM) when injected, at physiolog-
ical doses, into hypothyroid rats [9]. This stimulatory e¡ect of
T2s on RM is independent of an e¡ect on the protein syn-
thesis and is more rapid than that exerted by T3, with 3,5-T2
showing a clearer e¡ect (see Fig. 1 and [59]). In these experi-
ments, we basically followed the experimental design em-
ployed by J.R. Tata [2,3], with the exception that in our
case, the hypothyroidism was induced by simultaneous admin-
istration of PTU and iopanoic acid (IOP). This treatment
induces a severe hypothyroidism and, at the same time, pro-
duces a strong inhibition of deiodinase enzymes, thus permit-
ting us to exclude the possibility that a proportion of the
e¡ects consequent to the administration of iodothyronines
might be due to some of their deiodinated products (see Sec-
tion 1). In normal animals (i.e. those in which deiodinase
activities are not inhibited), such a possibility cannot be ex-
cluded in experiments involving the injection of either T4 or
T3. In fact, in the papers by J.R. Tata and co-workers, the
authors noted that when T3 was injected into normal animals,
rather than hypothyroid animals, a di¡erent steepness of the
curve showing a change in the basal metabolic rate as a func-
tion of time was observed. In our laboratory, after injecting
T3 into normal animals, we have observed the same phenom-
enon (unpublished results), that is that the time course of the
increase in RM looks much like the e¡ect elicited by 3,5-T2.
Taken together, these recent ¢ndings furnish support for a
direct mitochondrial pathway mediating the actions of thyroid
hormone. They also indicate that the diiodothyronines (or at
least 3,5-T2, because it shows the clearest e¡ect on RM)
should be considered an active iodothyronine and not a sim-
ple product of T4 or T3 metabolism.
4. Conclusion
It would be convenient, not to say desirable, to explain the
various actions of thyroid hormones at the cellular level by a
unitary molecular model. However, while this is an attractive
idea, the bulk of available evidences indicates that the situa-
tion is far more complicated. In addition, the evidence coming
from several laboratories showing that iodothyronines other
than T4 and T3 possess relevant physiological properties have
further complicated the picture. With regard to the e¡ects
they exert on the energy metabolism, however, it seems quite
clear at the moment that there are two ways by which iodo-
thyronines may regulate mitochondrial functions. The ¢rst
way is ‘nuclear-mediated’ and involves a regulation of the
synthesis of respiratory genes and of mtTFs, T3 is the princi-
pal mediator in this pathway. The second way is a direct
action on mitochondria. In this pathway, T3 and T2 may
both be involved. T3, by binding to a speci¢c mitochondrial
receptor and a¡ecting the transcription apparatus, may thus
act in a coordinate manner with the T3 nuclear pathway to
regulate the mitochondrial biogenesis and turnover. T2s, or at
least 3,5-T2, seem to act directly on the energy transduction
apparatus by binding with some components of the respira-
tory chain (such as subunit Va of the COX complex), thus
regulating the coupled and uncoupled respiration.
Concerning their action at the transcriptional level, it seems
well-established that thyroid hormones regulate both nuclear
and mitochondrial transcription, but some questions remain
unanswered. For example, do the e¡ects that the hormones
exert on the nuclear and mitochondrial transcription function
Fig. 1. Changes in the RM of hypothyroid rats following adminis-
tration of a single dose of iodothyronines (25 Wg/100 g BW) with or
without actinomycin D (8 Wg/100 g BW). Hypothyroidism was in-
duced by combined treatment with PTU and IOP. The metabolic
rate of each rat at time 0 (immediately before the injection) is given
the value 100.
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(a) so as to produce organelles richer in respiratory compo-
nents, (b) so as to produce organelles more or less e⁄cient in
the ATP synthesis or (c) so as to regulate the mitochondrial
turnover? It seems unlikely, to us, that a rapid regulation of
the mitochondrial respiration is achieved by synthesizing res-
piratory components to be inserted into pre-existing mem-
branes. It is more likely that in the regulation of cellular
respiration by iodothyronines, a double mechanism is opera-
tive. One would be a short-term mechanism, useful for a rapid
response to sudden physiological variations in the energy re-
quirement. Diiodothyronines, or at least 3,5-T2, may play an
important role in this mechanism through a direct interaction
with some mitochondrial components. The other would be a
long-term mechanism, useful for responding to chronic stimuli
(days or weeks) such as a long period of cold exposure or a
change in the diet or developmental stage. T3, through the
regulation of both the nuclear and the mitochondrial tran-
scription apparatuses, would play an important role in this
second mechanism. This long-term mechanism would ulti-
mately produce a new mitochondrial population that is
more or less active (depending on the presence of respiratory
components or cristae) and/or more or less e⁄cient (depend-
ing on the presence of UCPs, AAC etc.).
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